Osteoclasts are inhibited by
**Core Concept**
Osteoclasts are bone-resorbing cells that play a crucial role in bone remodeling. The inhibition of osteoclasts is essential in treating bone-related disorders such as osteoporosis.
**Why the Correct Answer is Right**
Osteoclasts are inhibited by bisphosphonates, which bind to hydroxyapatite in bone and are internalized by osteoclasts, leading to the inhibition of osteoclast function and apoptosis. This results in a decrease in bone resorption and an increase in bone density. Bisphosphonates also interfere with the mevalonate pathway, which is essential for the post-translational modification of proteins involved in osteoclast function.
**Why Each Wrong Option is Incorrect**
**Option A:** Estrogen is not a direct inhibitor of osteoclasts, although it does have an indirect effect on bone metabolism by promoting the activity of osteoblasts. Estrogen deficiency is associated with an increase in osteoclast activity, leading to bone loss.
**Option B:** Calcitonin is a hormone that has a direct inhibitory effect on osteoclasts by decreasing osteoclast activity and increasing osteoblast activity. However, it is not the primary inhibitor of osteoclasts.
**Option C:** Vitamin D is essential for bone health, but it does not directly inhibit osteoclasts. In fact, vitamin D promotes the activity of osteoclasts, which is necessary for calcium absorption and bone mineralization.
**Clinical Pearl / High-Yield Fact**
Bisphosphonates are a class of medications that are commonly used to treat osteoporosis and other bone-related disorders. They work by inhibiting osteoclasts, which are responsible for bone resorption.
**Correct Answer: D. Bisphosphonates**